Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progressive supranuclear palsy--20 years later.

M O Kristensen

    Acta Neurologica Scandinavica
    |March 1, 1985
    PubMed
    Summary

    Progressive supranuclear palsy (PSP) remains a neurodegenerative disease with unknown etiology. Current understanding highlights key clinical features, diagnostic challenges, and neuropathological hallmarks, emphasizing the need for further research.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Can the use of cesarean section be regulated? A review of methods and results.

    Acta obstetricia et gynecologica Scandinavica·1998
    Same author

    A clinical trial of dextromethorphan in amyotrophic lateral sclerosis.

    Acta neurologica Scandinavica·1997
    Same author

    Serum cobalamin and methylmalonic acid in Alzheimer dementia.

    Acta neurologica Scandinavica·1993
    Same author

    [Neurotransmitters in Alzheimer's disease].

    Ugeskrift for laeger·1990
    Same author

    Methylmalonic acid concentrations in serum of normal subjects: biological variability and effect of oral L-isoleucine loads before and after intramuscular administration of cobalamin.

    Clinical chemistry·1990
    Same author

    [Complaints following treatment of common acute eye diseases].

    Ugeskrift for laeger·1990

    Area of Science:

    • Neurology
    • Neuroscience
    • Pathology

    Background:

    • Progressive supranuclear palsy (PSP) has been recognized as a distinct clinicopathological entity for two decades.
    • The etiology of PSP is currently unknown.
    • PSP presents with characteristic supranuclear gaze palsy, axial rigidity, and pseudobulbar symptoms, often accompanied by cognitive and other neurological deficits.

    Purpose of the Study:

    • To delineate the current state of knowledge regarding progressive supranuclear palsy (PSP).
    • To review the clinical, diagnostic, and neuropathological aspects of PSP.
    • To outline the importance of ongoing research in PSP.

    Main Methods:

    • Literature review of studies published since the recognition of PSP as a clinicopathological entity.
    • Analysis of clinical hallmarks, accessory features, and epidemiological data.
    • Evaluation of current diagnostic tools and neuropathological findings.

    Main Results:

    • PSP typically affects individuals in their late 50s, with a male predominance.
    • Early symptoms include dysequilibrium, mental changes, and visual disturbances, often preceding definitive neurological signs.
    • Neuropathological findings include neurofibrillary tangles, neuron loss, and gliosis in specific brain regions.

    Conclusions:

    • Distinguishing PSP from parkinsonism is crucial due to poor treatment response and rapid progression in PSP.
    • CT scanning and specialized neuro-examinations show promise as diagnostic tools.
    • Further research into neurocytochemistry, brain ultrastructure, and immunology is vital for advancing PSP understanding and treatment.

    Related Experiment Videos